Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Generic Amlodipine/Valsartan vs Exforge
NCT06193044Phase 1Not yet recruiting
- Sponsor
- International Bio Service
- Start
- May 2024
- Primary completion
- Jul 2024
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of amlodipine + valsartan in hypertension (HTN), sponsored by International Bio Service. Planned start May 2024; status: not yet recruiting.
02
Drugs
amlodipine + valsartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT06193044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06193044.